Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Sramek

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Journal of Clinical Pharmacology|August 1, 1995
The safety and tolerance of xanomeline tartrate in patients with Alzheimer's diseaseJ J Sramek, D J Hurley, T S Wardle, et al.
Depression and Anxiety|January 1, 1997
Adverse events in placebo-treated patients with generalized anxiety disorderJ J Sramek, E J Frackiewicz, M A Piercy, et al.
Psychopharmacology Bulletin|October 8, 1999
A bridging study of fananserin in schizophrenic patientsJ J Sramek, S Kirkesseli, A Paccaly-Moulin, et al.
Cephalalgia : an International Journal of Headache|April 1, 1996
Pilot study of MK-462 in migraineN R Cutler, J Claghorn, J J Sramek, et al.
The Annals of Pharmacotherapy|June 1, 1996
Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patientsN R Cutler, J J Sramek, A Luna, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacinN R Cutler, J Vincent, S S Jhee, et al.
Journal of Geriatric Psychiatry and Neurology|April 1, 1993
Evaluation of multiple doses of milacemide in the treatment of senile dementia of the Alzheimer's typeN R Cutler, T D Fakouhi, W T Smith, et al.
Acta Neurologica Scandinavica|May 12, 1998
Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's diseaseN R Cutler, R J Polinsky, J J Sramek, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humansE P Brass, R Polinsky, J J Sramek, et al.
The American Journal of Cardiology|June 1, 1995
Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectorisN R Cutler, R J Anders, S S Jhee, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Journal of Clinical Pharmacology|August 1, 1995
The safety and tolerance of xanomeline tartrate in patients with Alzheimer's diseaseJ J Sramek, D J Hurley, T S Wardle, et al.
Depression and Anxiety|January 1, 1997
Adverse events in placebo-treated patients with generalized anxiety disorderJ J Sramek, E J Frackiewicz, M A Piercy, et al.
Psychopharmacology Bulletin|October 8, 1999
A bridging study of fananserin in schizophrenic patientsJ J Sramek, S Kirkesseli, A Paccaly-Moulin, et al.
Cephalalgia : an International Journal of Headache|April 1, 1996
Pilot study of MK-462 in migraineN R Cutler, J Claghorn, J J Sramek, et al.
The Annals of Pharmacotherapy|June 1, 1996
Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patientsN R Cutler, J J Sramek, A Luna, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacinN R Cutler, J Vincent, S S Jhee, et al.
Journal of Geriatric Psychiatry and Neurology|April 1, 1993
Evaluation of multiple doses of milacemide in the treatment of senile dementia of the Alzheimer's typeN R Cutler, T D Fakouhi, W T Smith, et al.
Acta Neurologica Scandinavica|May 12, 1998
Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's diseaseN R Cutler, R J Polinsky, J J Sramek, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humansE P Brass, R Polinsky, J J Sramek, et al.
The American Journal of Cardiology|June 1, 1995
Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectorisN R Cutler, R J Anders, S S Jhee, et al.
Pageof 11